R1	Has_value Arg1:T3 Arg2:T2	
R2	AND Arg1:T1 Arg2:T3	
*	OR T5 T6 T7
R3	Subsumes Arg1:T4 Arg2:T5	
*	OR T1 T4
R6	Has_temporal Arg1:T14 Arg2:T16	
R5	Has_negation Arg1:T12 Arg2:T18	
R7	Has_context Arg1:T13 Arg2:T14	
*	OR T12 T13
R9	AND Arg1:T1 Arg2:T9	
R8	AND Arg1:T9 Arg2:T12	
R10	Has_negation Arg1:T20 Arg2:T21	
R11	AND Arg1:T29 Arg2:T28	
*	OR T27 T29
R12	Has_value Arg1:T26 Arg2:T27	
R13	Has_value Arg1:T25 Arg2:T27	
R14	Has_value Arg1:T23 Arg2:T24	
*	OR T23 T25
R15	Subsumes Arg1:T20 Arg2:T23	
R16	Subsumes Arg1:T32 Arg2:T33	
R17	Has_temporal Arg1:T37 Arg2:T38	
R18	Has_qualifier Arg1:T32 Arg2:T34	
R19	Has_temporal Arg1:T34 Arg2:T35	
R20	Has_qualifier Arg1:T36 Arg2:T37	
R21	Has_value Arg1:T39 Arg2:T40	
R22	Has_value Arg1:T41 Arg2:T42	
R23	Has_value Arg1:T44 Arg2:T45	
R24	Has_temporal Arg1:T44 Arg2:T46	
R25	AND Arg1:T43 Arg2:T44	
*	OR T47 T48 T49
*	OR T45 T47
R26	multi Arg1:T53 Arg2:T15	
R27	Has_index Arg1:T16 Arg2:T53	
R4	Has_negation Arg1:T10 Arg2:T54	
R28	Has_qualifier Arg1:T9 Arg2:T10	
*	OR T20 T19
R29	AND Arg1:T45 Arg2:T44	
R30	AND Arg1:T45 Arg2:T46	
T1	Condition 28 55	metastatic carcinoid tumors
T2	Value 21 27	proven
T3	Procedure 14 20	biopsy
T4	Condition 59 86	other neuroendocrine tumors
T5	Condition 88 98	Islet cell
T6	Condition 100 111	Gastrinomas
T7	Condition 116 123	VIPomas
T9	Condition 143 160	measurable lesion
T10	Qualifier 173 177	bone
T12	Procedure 215 225	irradiated
T13	Procedure 243 253	irradiated
T14	Observation 271 282	progression
T15	Procedure 293 310	radiation therapy
T16	Temporal 283 310	since the radiation therapy
T18	Negation 195 203	not been
T19	Condition 331 356;368 376	major impairment of renal function
T20	Condition 331 350;360 376	major impairment of hepatic function
T21	Negation 328 330	no
T23	Measurement 429 444	total bilirubin
T24	Value 445 455	<1.5 X ULN
T25	Measurement 457 460	AST
T26	Measurement 462 465	ALT
T27	Value 465 474	<2.5X ULN
T28	Condition 488 504	liver metastases
T29	Value 476 484	<5 X ULN
T32	Drug 531 546	Sandostatin Lar
T33	Drug 548 581	long acting somatostatin analogue
T34	Qualifier 596 607	stable dose
T35	Temporal 608 640	for 30 days prior to study entry
T36	Drug 645 680	short acting somatostatin analogues
T37	Qualifier 707 729	clinically stable dose
T38	Temporal 750 770	prior to study entry
T39	Observation 784 799	life expectancy
T40	Value 803 832	greater than three (3) months
T41	Measurement 834 862	Karnofsky Performance Status
T42	Value 863 867	> 60
T43	Person 869 875	Female
T44	Measurement 906 926	serum pregnancy test
T45	Value 897 905	negative
T46	Temporal 927 939	at screening
T47	Procedure 974 996	bilateral oophorectomy
T48	Procedure 1004 1016	hysterectomy
T49	Condition 1046 1060	postmenopausal
T53	Reference_point 293 310	radiation therapy
T54	Negation 162 172	other than
